首页 | 本学科首页   官方微博 | 高级检索  
检索        

TC方案化疗联合同期放疗治疗中晚期鼻咽癌临床观察
引用本文:邹雨荷,田鲜艳,何景扬,王羽,张钦华.TC方案化疗联合同期放疗治疗中晚期鼻咽癌临床观察[J].现代肿瘤医学,2011,19(1):29-31.
作者姓名:邹雨荷  田鲜艳  何景扬  王羽  张钦华
作者单位:广东省江门市中心医院肿瘤科,广东,江门,529030
摘    要:目的:观察紫杉醇+卡铂同期放化疗治疗中晚期鼻咽癌的疗效及不良反应。方法:86例确诊为中晚期鼻咽癌患者随机分为治疗组TC同期放化疗组42例和对照组PF同期放化疗组44例,TC组在放射治疗的第1、4周给予2个周期紫杉醇+卡铂方案化疗(紫杉醇135mg/m2d1,卡铂AUC=6 d1;PF组在放射治疗的第1、4周给予2个周期5-FU+顺铂方案化疗(顺铂20mg/m2iv d1-5,5-FU 500 mg/m2)。结果:TC组1、3年生存率分别为100%(42/42)、73.8%(36/50),PF组91.0%(43/44)、78.0%(35/44)(P>0.05);TC组口腔黏膜损伤、消化道反应明显低于PF组(P<0.05)。两组局部控制率、远处转移率及骨髓功能抑制无统计学差异(P>0.05)。结论:紫杉醇+卡铂同步放化疗治疗局部晚期鼻咽癌耐受性好,疗效满意。

关 键 词:鼻咽癌  同步放化疗  紫杉醇  卡铂

A clinical research of docetaxel plus carboplatin with concurrent radiotherapy in the treatment of locally advanced nasopharyngeal carcinoma
ZOU Yu-he,TIAN Xian-yan,HE Jing yang,WANG Yu,ZHANG Qin-hua.A clinical research of docetaxel plus carboplatin with concurrent radiotherapy in the treatment of locally advanced nasopharyngeal carcinoma[J].Journal of Modern Oncology,2011,19(1):29-31.
Authors:ZOU Yu-he  TIAN Xian-yan  HE Jing yang  WANG Yu  ZHANG Qin-hua
Institution:ZOU Yu-he,TIAN Xian-yan,HE Jing yang,WANG Yu,ZHANG Qin-hua Department of oncology,the Central Hospitol of Jiangmen city,guangdong 529070,China.
Abstract:Objective:To evaluate the effect and toxicity of docetaxel plus carboplatin with concurrent radiotherapy in the treatment of locally advanced nasopharyngeal carcinoma.Methods:Total of 86 cases with locally advanced nasopharyngeal carcinoma(stage III and IVa)were randomized into 2 groups.Group TC(n=42) received radiotherapy with docetaxel plus carboplatin(docetaxel 135mg/m2 d1,carboplatin AUC=6 d1).Group PF(n=44)received cisplatin 20mg/ m2 iv d1-5,5-FU 500 mg/ m2 iv d1-5 at the 1st and 4th week and received ...
Keywords:nasopharyngeal carcinoma  concurrent radiochemotherapy  carboplatin  docetaxel  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号